Concepedia
Statistics
Publications
34
Citations
1.7K
H-Index
26
Active since
1988
Affiliations
Novartis (Switzerland)(Current)
Novartis Institutes for BioMedical Research
Goethe University Frankfurt
Genomics Institute of the Novartis Research Foundation
Karlsruhe Institute of Technology
Roland Feifel is an author at Novartis (Switzerland) specializing in pharmacology, medicinal chemistry, and drug discovery.
Publications per year
1988–2023
Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK
Rudolf Waelchli, Birgit Bollbuck, Christian Bruns et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 148 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +8
ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-α
Gerald Künstle, Marcel Leist, Stefan Uhlig et al. · Immunology Letters · 1997 · 136 citations
Life Sciences, Cell Biology, Immunology +14
p-fluoro-hexahydro-sila-difenidol: The first M2β-selective muscarinic antagonist
Günter Lambrecht, Roland Feifel, Bernhard Forth et al. · European Journal of Pharmacology · 1988 · 129 citations
Medicine, Medicinal Chemistry, Pharmacology +8
Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes
Günter Lambrecht, Roland Feifel, Monika Wagner-Röder et al. · European Journal of Pharmacology · 1989 · 105 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +16
The Role of Interstitial Macrophages in Nephropathy of Type 2 Diabetic db/db Mice
Volha Ninichuk, Alexander G. Khandoga, Stephan Segerer et al. · American Journal Of Pathology · 2007 · 92 citations · Full text
Medicine, Immunology, Pathology +16
1–5 of 34